M. van der Zwan

发表

Specification of service level agreements, clarifying concepts on the basis of practical research

J. Bouman, J. Trienekens, M. van der Zwan, 1999, STEP '99. Proceedings Ninth International Workshop Software Technology and Engineering Practice.

Costimulation Blockade in Kidney Transplant Recipients

M. van der Zwan, D. Hesselink, M. V. D. van den Hoogen, 2019, Drugs.

The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy

M. van der Zwan, W. Weimar, D. Hesselink, 2018, Annals of transplantation.

Structural analysis of the phase-variable lipooligosaccharide from Haemophilus somnus strain 738.

J. Brisson, M. van der Zwan, P. Thibault, 1998, European journal of biochemistry.

Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms

M. van der Zwan, D. Hesselink, J. Janssen, 2018, Transplantation direct.

Targeted Proteomic Analysis Detects Acute T Cell-Mediated Kidney Allograft Rejection in Belatacept-Treated Patients.

M. van der Zwan, D. Hesselink, M. C. Clahsen‐van Groningen, 2019, Therapeutic drug monitoring.

Short communication: Targeted proteomic analysis detects acute T cell-mediated kidney allograft rejection in belatacept-treated patients.

M. van der Zwan, D. Hesselink, M. C. Clahsen‐van Groningen, 2018, Therapeutic drug monitoring.

Synthesis and NMR assignment of two repeating units (decasaccharide) of the type III group B Streptococcus capsular polysaccharide and its 13C-labeled and N-propionyl substituted sialic acid analogues.

J. Brisson, M. van der Zwan, H. Jennings, 1996, Carbohydrate research.

NMR and molecular dynamics studies of the conformational epitope of the type III group B Streptococcus capsular polysaccharide and derivatives.

J. Brisson, D. Kasper, M. van der Zwan, 1997, Biochemistry.

Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation

M. van der Zwan, D. Hesselink, T. van Gelder, 2017, Clinical Pharmacokinetics.

Structural analysis of the lipopolysaccharide from the nontypable Haemophilus influenzae strain SB 33.

J. Brisson, M. van der Zwan, P. Thibault, 2001, European journal of biochemistry.

Acquired haemophilia A after alemtuzumab therapy

M. van der Zwan, D. Hesselink, F. Leebeek, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

A family affair? Exploratory insights into the role of family members of those who joined jihadist groups

M. van der Zwan, M. Liem, D. Weggemans, 2021, Security Journal.

Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant Rejection

M. van der Zwan, D. Hesselink, S. Baart, 2022, Clinical pharmacology and therapeutics.

Molecular Analysis of Renal Allograft Biopsies: Where Do We Stand and Where Are We Going?

M. van der Zwan, D. Hesselink, J. Becker, 2020, Transplantation.

Chronic Active Antibody Mediated Rejection: To Belatacept or Not, That Is the Hot Question.

M. van der Zwan, D. Hesselink, M. C. Clahsen‐van Groningen, 2020, Transplantation.

Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection

M. van der Zwan, D. Roelen, D. Hesselink, 2020, Frontiers in Immunology.

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients

M. van der Zwan, R. Colvin, D. Hesselink, 2018, Transplantation direct.

The Practitioner's Guide to the Galaxy - A Comparison of Risk Assessment Tools for Violent Extremism

M. van der Zwan, Liesbeth van der Heide, Marteen van Leyenhorst, 2019, ICCT Research Paper.